Epidemiology and outcomes of pediatric cardiac arrest in a cardiovascular unit at a public hospital in Argentina.

Background: Children with congenital heart disease present a higher frequency of cardiorespiratory arrest (CRA) than the general pediatric population. The epidemiology of CRA is not exactly known in our setting, nor are the mortality risk or the neurological evolution factors.

Objective: To describe the epidemiology and outcomes associated with pediatric cardiopulmonary resuscitation in a cardiovascular recovery unit.

Extracorporeal Membrane Oxygenation (ECMO) Training Program in A Pediatric Cardiac Intensive Care Unit: An 8-Year Single-Center Experience in Argentina.

Introduction: Extracorporeal membrane oxygenation (ECMO) for temporary cardiopulmonary support is one of the most intense and technologically complex therapies offered in medicine. It is a high-risk procedure that requires specific knowledge and technical skills to perform it with good results.

Objective: The main goal of this study is to describe our extracorporeal membrane oxygenation (ECMO) training program based on the study of specialized nurses and physicians of a simulation teaching experience, conducted in a pediatric cardiac intensive care unit.

Impact of the COVID-19 pandemic on a pediatric cardiovascular surgery program of a public hospital from Argentina.

Objective: To describe the impact of the COVID-19 pandemic on a pediatric cardiovascular surgery program and estimate the necessary time to reduce the surgery waiting list.

Methods: Retrospective, descriptive study. Surgical outcomes from the pre-COVID-19 period and COVID-19 period were compared.

Extracorporeal membrane oxygenation in pediatric cardiovascular care: Experience of a center in Argentina.

Objective: To describe the results of extracorporeal membrane oxygenation in patients undergoing heart surgery and analyze the risk factors for morbidity and mortality.

Methods: Retrospective study conducted in cardiac patients under circulatory support. Outcome measures, diagnosis, surgery, Risk Adjustment for Congenital Heart Surgery (RACHS) score, implantation time, cannulation, length of support during stay, complications, survival, and follow-up were recorded.

Meeting nutritional needs of infants under 3 months of life within the first week after cardiovascular surgery.

Background: After heart surgery requiring cardiopulmonary bypass, neonates have a profound metabolic response to stress. If adequate nutritional support is not provided this leads to loss of lean mass and deterioration of vital organs. The objective of this study was to describe the nutritional status and nutritional support achieved in infants younger than 3 months of life undergo in cardiovascular surgery.

Morbidity in congenital heart surgery in a public hospital in Argentina.

Objective: To describe the complications associated with heart surgery, compare them to a reference population, and identify mortality risk factors.

Patients And Methods: Retrospective and descriptive study. All patients who underwent surgery at Hospital Garrahan in the 2013-2015 period were included.

Impact of the time of diagnosis on the postoperative outcome of newborn infants with congenital heart disease in a public hospital in Argentina.

Congenital heart diseases account for 13% of child mortality, and late diagnosis increases morbidity and mortality. The objective of this study was to assess the impact of the time of diagnosis in newborn infants on the postoperative course. The time of diagnosis was classified into prenatal, before or after discharge from the maternity center.

[Congenital heart disease: surgical results in a public hospital in Argentina].

Objective: To describe the results of congenital heart surgery at the Hospital de Pediatría J. P.Garrahan.

Clinical experience with Berlin Heart Excor in pediatric patients in Argentina: 1373 days of cardiac support.

The objective of this study was to describe our experience (1373 days of support) with the Berlin Heart Excor (BH) ventricular-assist device (VAD) as bridging to cardiac transplantation in pediatric patients with end-stage cardiomyopathy. This study involved a retrospective observational cohort. Records of patients supported with the BH VAD were reviewed.